For newly diagnosed met #pancreas #cancer: The phase III #arcusbiosciences PRISM-1 trial is open:
💠NCT06608927
💠Gem/Nab-paclitaxel +/- Quemlicustat (Q)
💠Based on promising Ib activity
💠Q is a CD73 inhibitor to enhance antitumor immunity
#DrDanaCardinMD @pancan.bsky.social #cancerresearch